Eastwood Bio-Medical Canada Inc.
EBM.VTSXVConsumer Defensive● Active
$0.95
+$0.09(+10.47%)
Market Cap$65441671
P/E Ratio—
52W High$1.1
52W Low$0.295
Eastwood Bio-Medical Canada Inc.（EBM.V）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · EBM.V · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-10 | 2024-10 | 2023-10 | 2022-10 | 2021-10 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.78M | $0.70M | $0.87M | $1.30M | $0.98M |
| Cost of Revenue | $0.28M | $0.25M | $0.43M | $0.40M | $0.52M |
| Gross Profit | $0.51M | $0.45M | $0.44M | $0.90M | $0.46M |
| Gross Margin %(computed) | 64.70% | 64.72% | 50.75% | 69.45% | 46.72% |
| Operating Expenses | |||||
| R&D Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $0.52M | $0.67M | $0.92M | $0.95M |
| Total Operating Expenses | $0.86M | $0.89M | $0.95M | $1.03M | $1.05M |
| Operating Income | ($0.35M) | ($0.44M) | ($0.51M) | ($0.13M) | ($0.59M) |
| Operating Margin %(computed) | -45.35% | -62.34% | -58.30% | -9.91% | -60.23% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.01M | $0.01M | $0.03M | $0.01M | $0.00M |
| Income Before Tax | ($0.33M) | ($0.46M) | ($0.55M) | ($0.15M) | ($0.60M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.01M | $0.01M |
| Net Income | ($0.33M) | ($0.46M) | ($0.55M) | ($0.16M) | ($0.61M) |
| Net Margin %(computed) | -42.55% | -64.93% | -62.98% | -12.35% | -62.31% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.00 | $-0.01 | $-0.01 | $-0.00 | $-0.01 |
| Wtd Avg Shares | 68.89M | 68.89M | 68.89M | 68.89M | 68.89M |
| EBITDA | ($0.31M) | ($0.34M) | ($0.41M) | ($0.03M) | ($0.50M) |
| EBITDA Margin %(computed) | -39.60% | -48.72% | -47.31% | -2.49% | -50.51% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · CAD · M
深入了解Eastwood Bio-Medical Canada Inc.
关于Eastwood Bio-Medical Canada Inc.（EBM.V）损益表
Eastwood Bio-Medical Canada Inc.（EBM.V）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，EBM.V实现营收$0.00B，毛利润$0.00B（毛利率64.70%），净利润($0.00B)（净利率-42.55%）。
常见问题
EBM.V · 4 问Eastwood Bio-Medical Canada Inc.（EBM.V）2025财年营收为$0.00B，同比up11.4%。
EBM.V revenueEBM.V salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08